In our initial description of LQTS-associated calmodulinopathy (6) we provided preliminary evidence that the CaM mutations identified exhibited reduced affinity for Ca2+ and were thereby predicted to interfere with CaM's ability to transduce Ca2+-mediated signals. This evidence concerns the gene CALM1 and familial long QT syndrome.